Quantum Biopharma (TSE:QNTM) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Quantum BioPharma has successfully closed its first tranche of an offering, raising $500,000 to advance its business development and for general working capital. The company, known for its innovative solutions in treating neurodegenerative disorders, remains dedicated to its research, particularly on its lead compound Lucid-MS.
For further insights into TSE:QNTM stock, check out TipRanks’ Stock Analysis page.
